Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate Control
6,7-Dihydroquinolin-8(5H)-one is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a critical building block for the production of various bioactive molecules, facilitating the development of novel therapeutic agents. Its structural characteristics enable diverse chemical modifications, making it valuable in drug discovery and medicinal chemistry applications. -
Drug Intermediate
Ethyl 2-(4-hydroxyphenoxy)acetate serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its chemical structure facilitates the incorporation of the phenoxy group, enhancing the biological activity of derived products. This compound is pivotal in medicinal chemistry studies focused on developing novel therapeutic agents. -
Drug Intermediate
tert-Butyl 2-(1-(4-(ethoxycarbonyl)phenyl)ethylidene)hydrazinecarboxylate serves as a versatile drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the development of innovative therapeutic agents by acting as a key building block in chemical reactions. Its structural characteristics make it valuable for researchers focused on drug discovery and synthetic chemistry applications. -
Drug Impurity
Olmesartan impurity 13 is a specific impurity associated with the angiotensin II receptor blocker, Olmesartan. This compound is important for analytical and quality control applications in pharmaceutical research, particularly in ensuring the purity and safety of Olmesartan formulations. Its presence can impact the efficacy and safety profile of the drug, making it a relevant focus in pharmacological studies and drug development processes. -
Drug Intermediate
(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine acts as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its unique trifluoromethoxy group enhances the pharmacological properties of the final products. This compound is instrumental in medicinal chemistry research, facilitating the development of new therapeutic agents. -
Drug Impurity
Amodiaquine impurity 1 is a drug impurity associated with Amodiaquine, a chloroquine derivative primarily utilized in antimalarial therapy. This impurity may impact the pharmacodynamics and stability of the parent compound, making it crucial for analytical and quality control studies in pharmaceutical research. Its characterization is essential for understanding drug formulation and ensuring compliance with regulatory standards. -
Drug Intermediate
Biphenyl-4-amidoxime is a synthetic intermediate with significant utility in pharmaceutical synthesis. This compound plays a crucial role in the development of various bioactive molecules and can facilitate the creation of potent drug candidates. Its application in the research and development of pharmaceuticals underscores its importance in medicinal chemistry. -
Drug Intermediate
Methyl 2-bromo-4-fluorobenzo[d]thiazole-6-carboxylate is a key drug intermediate known for its utility in the synthesis of diverse bioactive compounds. This compound serves as a versatile building block in medicinal chemistry, facilitating the development of novel therapeutic agents. Its unique structure contributes to various chemical modifications, making it valuable for research applications in drug discovery and development. -
Drug Intermediate
2-Methylindanone is a cyclic ketone compound that serves as a valuable substrate in the evaluation of palladium (Pd) and nickel (Ni) catalysts during asymmetric α-arylation reactions. Its utility as a drug intermediate enhances its relevance in synthetic organic chemistry. Researchers utilize 2-Methylindanone to explore novel synthetic pathways and develop pharmaceutical compounds. -
Drug Intermediate
Methyl 3-carbamoylbicyclo[1.1.1]pentane-1-carboxylate serves as a key drug intermediate, facilitating the synthesis of diverse bioactive compounds. Its unique bicyclic structure enhances its utility in the development of pharmaceutical agents. This reagent is vital for research focused on compound optimization and the exploration of novel therapeutic pathways. -
Drug Impurity
Nintedanib Impurity 6 is a drug impurity associated with the pharmaceutical compound Nintedanib, which acts as a multi-tyrosine kinase inhibitor. Its primary mechanism involves inhibiting kinases such as VEGFR, PDGFR, and FGFR, which are implicated in angiogenesis and tumor growth. This impurity may be used for analytical purposes in the development and quality control of Nintedanib, ensuring the integrity and safety of pharmaceutical formulations. Research applications include purity assessment and stability studies within pharmaceutical chemistry. -
Drug Intermediate
tert-Butyl (R)-3-(4-chlorophenyl)piperazine-1-carboxylate serves as an important drug intermediate utilized in the synthesis of diverse bioactive compounds. It plays a crucial role in the development of pharmaceuticals targeting various neurological and psychiatric disorders. This compound facilitates the exploration of new therapeutic options and enhances the efficiency of drug discovery processes. -
Drug Intermediate
(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one serves as a versatile drug intermediate in the synthesis of active pharmaceutical ingredients. This compound features the oxazolidinone core, which is instrumental in the development of various therapeutic agents. Its unique structural attributes facilitate the creation of novel bioactive molecules for research applications in medicinal chemistry and pharmaceutical development. -
Drug Intermediate
(R)-1-(Benzo[d][1,3]dioxol-5-yl)butan-1-amine hydrochloride serves as a vital drug intermediate in the synthesis of diverse pharmacologically active compounds. Its structural framework supports the development of various chemical entities, which are essential for medicinal chemistry research. This compound facilitates the exploration of new therapeutic agents and is valuable for those engaged in organic synthesis and drug development studies. -
Drug Impurity
Theophylline impurity 9 is a known impurity identified in Theophylline. This compound serves as an important reference standard in the analysis and quality control of pharmaceutical formulations. Its characterization is crucial for ensuring compliance with regulatory standards and for understanding the pharmacological profile of Theophylline-containing products in therapeutic and research contexts. -
Drug Impurity
Indobufen impurity 4 is a minor impurity derived from Indobufen, a known antiplatelet agent. This compound is relevant for analytical research in pharmacokinetics and quality control, allowing for comprehensive impurity profiling in drug formulations. Its characterization is essential for ensuring the safety and efficacy of therapeutic agents in development. -
Drug Intermediate
2-Fluorofluoren-9-one serves as an important drug intermediate for the synthesis of a variety of bioactive compounds. This compound possesses key structural features that make it pivotal in the development of pharmacologically relevant molecules. Its application extends to medicinal chemistry, where it can facilitate the formation of complex chemical structures for drug discovery and development. -
Drug Intermediate
4-Amino-6-bromo-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile is a chemical compound utilized as a drug intermediate in the synthesis of diverse bioactive molecules. With its unique structural features, it plays a critical role in the development of potential pharmaceuticals. This compound is significant in medicinal chemistry research, facilitating the creation of new therapeutic agents. -
Drug Impurity
N-Methyl-3-nitroaniline is a nitroaniline derivative primarily recognized for its role as a drug impurity. This compound is significant in chemical research for assessing purity levels and evaluating potential safety profiles of pharmaceutical formulations. N-Methyl-3-nitroaniline serves as a critical marker in stability studies and quality control processes within the drug development pipeline. -
Drug Impurity
Levetiracetam impurity 1 is a known impurity associated with the anticonvulsant agent Levetiracetam, primarily targeting the modulation of neurotransmitter release. This impurity can serve as a reference standard in analytical chemistry and pharmacokinetics studies, aiding in the evaluation of drug purity and stability. It is particularly useful in the development and quality control of pharmaceutical formulations containing Levetiracetam. -
Drug Impurity
Noradrenalone impurity 1 hydrochloride is a chemical compound characterized as an impurity of Noradrenalone. It serves as a reference standard for quality control in drug formulation and development, enabling researchers to investigate potential impurities in pharmaceutical products. This reagent is essential for ensuring the purity and safety of Noradrenalone in various biological and chemical research applications. -
Drug Intermediate
5-Methyl-8-hydroxycoumarin is a versatile drug intermediate, primarily utilized in the synthesis of a range of bioactive compounds. This molecule exhibits significant potential as a building block in organic chemistry, particularly in the development of pharmaceuticals and agrochemicals. Its unique structure and properties make it a valuable reagent in research and development settings focused on therapeutic applications. -
Drug Intermediate Control
D-2-Aminoglutarimide hydrochloride is a synthetic intermediate targeting the synthesis of hydantoins. This compound possesses anti-angiogenic properties and can induce differentiation in cancer cells, making it valuable for cancer research and drug development applications. Its role in the synthesis of bioactive molecules further supports studies in medicinal chemistry and potential therapeutic interventions. -
Drug Intermediate
2-(Benzyloxy)-4-fluorobenzaldehyde serves as an important drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound is characterized by its electrophilic aldehyde functionality, which facilitates further chemical transformations. It is widely used in organic synthesis and medicinal chemistry research to develop novel therapeutic agents. -
Drug Intermediate
5-Fluoro-2-methylpyridin-3-amine functions as a drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This pyridine derivative is significant in medicinal chemistry, aiding in the development of novel therapeutics. It is suitable for use in research applications focused on the design and optimization of drug candidates. -
Drug Intermediate
(2S,5S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-5-phenylpyrrolidine-2-carboxylic acid serves as an important drug intermediate in the synthesis of bioactive compounds. This compound is essential for the development of pharmaceuticals, providing a framework for various therapeutic agents. Its structural characteristics facilitate modifications that enhance biological activity, making it a valuable reagent in medicinal chemistry research. -
Drug Intermediate
3-Methoxyisoquinoline-1-carboxylic acid is a valuable drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical ingredients. This compound serves as a critical building block in the development of therapeutic agents, facilitating the formation of various isoquinoline derivatives. Its applications extend to medicinal chemistry, where it contributes to the discovery and optimization of novel drug candidates. -
Drug Intermediate
2-((1s,4s)-4-Phenylcyclohexyl)acetic acid serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. Its structural framework allows for the modification and development of novel pharmaceuticals, contributing to advancements in medicinal chemistry. This compound is of particular interest in the exploration of new therapeutic agents. -
Drug Impurity
Umeclidinium bromide impurity 8 is a known impurity of Umeclidinium bromide, which acts as a long-acting muscarinic antagonist (LAMA). This compound is primarily utilized for analytical purposes, especially in the characterization and quality control of pharmaceutical formulations containing Umeclidinium bromide. Its presence and quantification are crucial for ensuring compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Clozapine impurity 8 is a known impurity of the atypical antipsychotic clozapine, primarily identified for its role in therapeutic formulations. This compound is essential for assessing the quality and safety of clozapine, aiding in the understanding of its metabolic profile and overall pharmacological impact. Researchers can utilize this impurity in drug development and analytical studies to ensure compliance with regulatory standards for pharmaceutical products. -
Drug Intermediate
4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This compound facilitates the development of novel pharmaceuticals, playing a critical role in medicinal chemistry research. Its significant chemical structure allows researchers to explore a range of therapeutic applications, making it an essential reagent in the drug discovery process. -
Drug Intermediate
(5-Methyl-1-Tritylimidazol-4-yl)Methanol is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This compound plays a pivotal role in the development of pharmaceuticals, facilitating the formation of complex structures required for medicinal chemistry research. Its unique imidazole core and trityl group enhance reactivity and serve as essential building blocks in drug design. -
Drug Impurity
Tofacitinib impurity 6 is a chemical impurity associated with Tofacitinib, a selective Janus kinase (JAK) inhibitor. It is primarily used to support analytical evaluations and quality control in pharmaceutical research involving Tofacitinib. This compound is essential for the identification and quantification of impurities, facilitating the maintenance of drug safety and efficacy standards. -
Drug Impurity
Sildenafil Impurity 1 is a known impurity of the phosphodiesterase type 5 inhibitor, Sildenafil. Characterized for its relevance in pharmacological studies, this compound serves as a critical reference standard for quality control in the synthesis and analysis of Sildenafil. Its identification and quantification are essential in ensuring the purity and safety of pharmaceutical formulations containing Sildenafil. -
Drug Intermediate
2-Chloro-4-methyl-3-nitropyridine is a versatile pyridine derivative primarily utilized as a drug intermediate. It serves as a crucial building block in the synthesis of 2-methoxypyridine derivatives, which exhibit significant antibacterial and antituberculosis activities. This compound is valuable in medicinal chemistry for the development of new therapeutic agents targeting microbial infections. -
Drug Intermediate
Desmethyl nevanimibe is a drug intermediate and a demethyl precursor of the sterol O-acyltransferase 1 (SOAT1) inhibitor Nevanimibe (PD-132301). This compound plays a critical role in the synthesis of SOAT1 inhibitors, which are of interest in the study of lipid metabolism and associated diseases. Research applications include investigations into cholesterol metabolism and the potential therapeutic effects in treating metabolic disorders. -
Drug Intermediate
2-Bromo-3-methylpyridine is a heterocyclic compound that serves as a halomethylpyridine intermediate. This reagent is primarily utilized in the synthesis of platinum(IV) diazide complexes, offering valuable applications in drug discovery and development. Its structural features enable its role in further synthetic pathways, particularly in the creation of novel pharmaceuticals. -
Drug Intermediate
7-Aminodeacetoxycephalosporanic acid (7-ADCA) serves as a crucial intermediate in the synthesis of cephalosporin antibiotics. Its structure is essential for the development of various cephalosporin derivatives, which exhibit broad-spectrum antibacterial activity. 7-ADCA is widely utilized in pharmaceutical research and development for the formulation of novel antimicrobial agents. -
Drug Intermediate
2,4-Dibromo-5-nitropyridine is a trisubstituted pyridine derivative primarily utilized as a drug intermediate. This compound plays a crucial role in the synthesis of Rho kinase inhibitors, which are important in the study of various cellular processes and disease pathways, including cancer and cardiovascular disorders. Its reactivity and structural features make it valuable for research applications focused on the modulation of Rho kinase activity. -
Drug Intermediate
5-Bromo-3-fluoropicolinic acid is a key intermediate in the synthesis of pharmaceutical compounds, specifically used in the development of inhibitors targeting glycinamide ribonucleotide formyltransferase. This compound serves as a valuable building block in medicinal chemistry, facilitating the exploration of novel therapeutic agents. Its specific structural features support research applications in drug discovery and development. -
Drug Impurity
Paliperidone impurity 15 is a chemical impurity associated with the antipsychotic agent paliperidone. This impurity serves as a key component for studies focused on the characterization and analysis of pharmaceutical formulations. It is essential for quality control and regulatory compliance in the production of paliperidone and may be utilized in analytical research to elucidate the compound's purity profile. -
Drug Intermediate
4-Bromo-3-fluorobenzaldehyde is an important drug intermediate characterized by its role in the synthesis of triaryl dimer antibacterial compounds. This compound serves as a valuable building block in drug discovery and development, aiding researchers in the design of novel antibacterial agents. Its unique chemical structure makes it suitable for various applications in medicinal chemistry. -
Drug Intermediate
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a key drug intermediate in the synthesis of Tirzepatide, which functions as a dual agonist of the glucose-dependent insulinotropic peptide (GIP) and the glucagon-like peptide-1 receptor (GLP-1R). This compound is essential for research and development in diabetes therapeutics, as Tirzepatide enhances insulin secretion and improves glycemic control. Its structural features facilitate the exploration of peptide-based treatments for metabolic disorders. -
Drug Intermediate
GGFG-Exatecan TFA is a synthetic drug intermediate designed for use in antibody-drug conjugates (ADCs). This compound features a glycyl-glycyl-phenylalanyl-glycine (GGFG) tetrapeptide linker conjugated to Exatecan, a DNA topoisomerase I inhibitor. It plays a critical role in cancer research, facilitating the development of targeted therapeutic strategies. -
Drug Intermediate
2,2-Diethoxyethanol functions as a drug intermediate, particularly in the synthesis of pharmaceutical compounds. Its utility is notable in research focused on the treatment of Plasmodium falciparum infections, contributing to the development of potential antimalarial therapies. Researchers may leverage this compound to explore its efficacy and mechanisms within related biological assays. -
Drug Intermediate
17-Hydroxypregnenolone sulfate sodium is a crucial intermediate involved in adrenal and gonadal steroidogenesis. It serves as a precursor in the biosynthesis of various steroid hormones, including glucocorticoids and sex hormones. This compound is significant for research related to adrenal function development and has potential applications in studying neurosteroid-related diseases such as cognitive impairment and neurodegenerative disorders. -
Drug Intermediate
2-Bromo-3-methoxypyridine serves as a versatile drug intermediate, primarily utilized in the synthesis of the metabolite of Piroxicam. This compound is integral for researchers involved in pharmacological studies and the development of anti-inflammatory therapeutics. Its structural properties facilitate various chemical reactions, making it a valuable asset in drug discovery and development processes. -
Drug Impurity
Candesartan impurity 26 is a known impurity of the angiotensin II receptor blocker, Candesartan. Its presence is significant in the analysis of pharmaceutical formulations and quality control processes. This compound is essential for researchers conducting stability studies, impurity profiling, and regulatory compliance in drug development. -
Drug Intermediate
(1S,2S)-2-((R)-1-Phenylethylamino)cyclohexanol serves as an important drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound is employed in medicinal chemistry to facilitate the development of novel therapeutic agents. Its structural characteristics make it a valuable building block for further chemical transformations and applications in drug discovery. -
Drug Intermediate Control
tert-Butyl 1H-indol-4-ylcarbamate serves as a synthetic intermediate commonly employed in pharmaceutical synthesis. Its structure facilitates various chemical transformations, making it significant for the development of indole-based therapeutics. This compound is integral for researchers focusing on drug discovery and development processes.
